Nordic Pharma Consulting ApS: Financial statements 2017
CVR: 37368598
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Nordic Pharma Consulting ApS (CVR 37368598) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 5,989,446 and a net result of DKK 785,477 compared with DKK 619,789 the year before. That is an increase of 253.9% compared with the year before. Equity in the 2017 report amounted to DKK 855,267. The solvency ratio was 35.7%.
- Gross Profit
- DKK 5,989,446
- Profit/Loss
- DKK 785,477
- Equity
- DKK 855,267
- Total Assets
- DKK 2,394,030
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 6 mio. | 785 t. | 855 t. | - |
| 2016 | - | 1.7 mio. | 620 t. | 670 t. | - |
Official annual report
Keep an eye on Nordic Pharma Consulting ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout Nordic Pharma Consulting ApS
Nordic Pharma Consulting ApS is a Danish company of the type Anpartsselskab based in Bagsværd, founded in 2016. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Thomas Bill Madsen and Ray David Sossna. The company is owned by Bill Holding ApS and by.david ApS. The company has 11 employees (2026). In 2025, the company reported a gross profit of DKK 15,902,080 and a net result of DKK 3,684,788 compared with DKK 2,966,376 the year before. Equity in the 2025 report amounted to DKK 4,487,385.